Market Overview:
The global duck vaccines market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for duck vaccines due to the rising incidence of diseases in ducks. In addition, the growing awareness about preventive measures against diseases is also contributing to the growth of this market. The global duck vaccines market is segmented on the basis of type, application, and region. On the basis of type, it is divided into live vaccines and killed vaccines. Live vaccine segment held a dominant share in 2017 and is projected to maintain its dominance during forecast period as well owing to their high efficacy rates as compared with killed vaccine products available in markets currently.
Product Definition:
Duck vaccines are used to prevent diseases in ducks. They are important because they help keep ducks healthy and can help reduce the spread of disease.
Live Vaccines:
Live vaccines are attenuated (weakened) forms of viruses or bacteria that are used to stimulate the body's immune system to respond normally to the disease. In order for a vaccine to be effective, it must mimic an infectious agent and trigger the immune system's natural response. Some of these live vaccines include measles, German measles, polio, mumps, chickenpox and rubella.
Killed Vaccines:
Killed vaccines are used in duck vaccines market. These products are developed by using special chemicals which have the ability to trigger the immune system of animals against certain diseases. The most commonly used animal for vaccine development is duck because it is more susceptible to many diseases than other animals like cattle and sheep etc.
Ducks are very prone to many infectious diseases like Newcastle Disease, Avian Influenza, and Filovirus disease (H5N1).
Application Insights:
The demand for duck vaccines is expected to witness growth owing to the rising importance of poultry as a source of animal protein and high consumption levels among various population segments. The growing importance of poultry in the diets of people from developing countries is expected to drive demand over the forecast period.
North America was estimated as a dominant market for ducks by volume in 2017, attributed to presence of major manufacturers such as Merck & Co., Inc., Pfizer, Inc., and Elanco Animal Health Company. Vaccines produced by these companies are available at low costs which attracts customers from all walks of life including pet owners, farmers and others who raise backyard chickens or turkeys.
In addition, increasing production levels coupled with wide application scope has resulted in increased utilization which will further fuel product demand over the projected period. In U.S.
Regional Analysis:
North America dominated the global duck vaccines market in 2017. The presence of a strong research base, high healthcare expenditure and awareness levels coupled with the implementation of advanced technologies for disease control are some factors responsible for its large share. Moreover, increasing incidence of highly contagious diseases such as H5N1 avian influenza and highly pathogenic Avian Influenza (HPAI) in this region is further propelling demand for these vaccines.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising government initiatives pertaining to immunization programs against poultry-associated diseases along with growing investments by multinational companies towards R&D activities related to poultry vaccines are some factors anticipated boost regional growth during the forecast period.
Growth Factors:
- Increasing demand for duck meat and eggs is expected to drive the duck vaccines market growth.
- Growing awareness about the benefits of vaccination is anticipated to boost the demand for duck vaccines in near future.
- Rising number of outbreaks due to various viruses and diseases is projected to fuel the growth of Duck Vaccines market over the forecast period.
- Technological advancements in vaccine production are likely to create new opportunities for Duck Vaccines market players during forecast period 2017-2025 . 5) The increasing trend of using autogenous vaccines is estimated to propel the Duck Vaccines market growth over next few years
Scope Of The Report
Report Attributes
Report Details
Report Title
Duck Vaccines Market Research Report
By Type
Live Vaccines, Killed Vaccines
By Application
Avian Influenza Vaccine, Newcastle Disease Vaccine, Other
By Companies
Merial, CEVA, QYH Biotech, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health, DHN, Zoetis, ChengDu Tecbond, Elanco (Lohmann), FATRO, CAVAC, Vaksindo
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Duck Vaccines Market Report Segments:
The global Duck Vaccines market is segmented on the basis of:
Types
Live Vaccines, Killed Vaccines
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Avian Influenza Vaccine, Newcastle Disease Vaccine, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merial
- CEVA
- QYH Biotech
- Ringpu Biology
- Yebio
- Harbin Veterinary Research Institute
- Merck Animal Health
- DHN
- Zoetis
- ChengDu Tecbond
- Elanco (Lohmann)
- FATRO
- CAVAC
- Vaksindo
Highlights of The Duck Vaccines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Live Vaccines
- Killed Vaccines
- By Application:
- Avian Influenza Vaccine
- Newcastle Disease Vaccine
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Duck Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Duck vaccines are used to protect ducks from diseases.
Some of the major players in the duck vaccines market are Merial, CEVA, QYH Biotech, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health, DHN, Zoetis, ChengDu Tecbond, Elanco (Lohmann), FATRO, CAVAC, Vaksindo.
The duck vaccines market is expected to register a CAGR of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Duck Vaccines Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Duck Vaccines Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Duck Vaccines Market - Supply Chain
4.5. Global Duck Vaccines Market Forecast
4.5.1. Duck Vaccines Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Duck Vaccines Market Size (000 Units) and Y-o-Y Growth
4.5.3. Duck Vaccines Market Absolute $ Opportunity
5. Global Duck Vaccines Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Duck Vaccines Market Size and Volume Forecast by Type
5.3.1. Live Vaccines
5.3.2. Killed Vaccines
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Duck Vaccines Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Duck Vaccines Market Size and Volume Forecast by Application
6.3.1. Avian Influenza Vaccine
6.3.2. Newcastle Disease Vaccine
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Duck Vaccines Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Duck Vaccines Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Duck Vaccines Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Duck Vaccines Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Duck Vaccines Demand Share Forecast, 2019-2026
9. North America Duck Vaccines Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Duck Vaccines Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Duck Vaccines Market Size and Volume Forecast by Application
9.4.1. Avian Influenza Vaccine
9.4.2. Newcastle Disease Vaccine
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Duck Vaccines Market Size and Volume Forecast by Type
9.7.1. Live Vaccines
9.7.2. Killed Vaccines
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Duck Vaccines Demand Share Forecast, 2019-2026
10. Latin America Duck Vaccines Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Duck Vaccines Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Duck Vaccines Market Size and Volume Forecast by Application
10.4.1. Avian Influenza Vaccine
10.4.2. Newcastle Disease Vaccine
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Duck Vaccines Market Size and Volume Forecast by Type
10.7.1. Live Vaccines
10.7.2. Killed Vaccines
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Duck Vaccines Demand Share Forecast, 2019-2026
11. Europe Duck Vaccines Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Duck Vaccines Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Duck Vaccines Market Size and Volume Forecast by Application
11.4.1. Avian Influenza Vaccine
11.4.2. Newcastle Disease Vaccine
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Duck Vaccines Market Size and Volume Forecast by Type
11.7.1. Live Vaccines
11.7.2. Killed Vaccines
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potental Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Duck Vaccines Demand Share, 2019-2026
12. Asia Pacific Duck Vaccines Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Duck Vaccines Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Duck Vaccines Market Size and Volume Forecast by Application
12.4.1. Avian Influenza Vaccine
12.4.2. Newcastle Disease Vaccine
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Duck Vaccines Market Size and Volume Forecast by Type
12.7.1. Live Vaccines
12.7.2. Killed Vaccines
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Duck Vaccines Demand Share, 2019-2026
13. Middle East & Africa Duck Vaccines Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Duck Vaccines Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Duck Vaccines Market Size and Volume Forecast by Application
13.4.1. Avian Influenza Vaccine
13.4.2. Newcastle Disease Vaccine
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Duck Vaccines Market Size and Volume Forecast by Type
13.7.1. Live Vaccines
13.7.2. Killed Vaccines
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Duck Vaccines Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Duck Vaccines Market: Market Share Analysis
14.2. Duck Vaccines Distributors and Customers
14.3. Duck Vaccines Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Merial
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. CEVA
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. QYH Biotech
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Ringpu Biology
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Yebio
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Harbin Veterinary Research Institute
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Merck Animal Health
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. DHN
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Zoetis
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. ChengDu Tecbond
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Elanco (Lohmann)
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. FATRO
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. CAVAC
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Vaksindo
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
